⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TAK News
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
prnewswire.com
HELP
TAK
AZN
JNJ
ABBV
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
businesswire.com
TAK
Life Sciences Analytics Market Advances to US$ 23.17 Billion by 2033 on AI-Driven Drug Discovery and Cloud Platforms Says Astute Analytica
globenewswire.com
JNJ
AZN
MRK
ORCL
IQV
PFE
NVS
TAK
BMY
SNY
LLY
GILD
ACN
DLTR
IBM
Iambic Announces Collaboration with Takeda to Advance AI-Driven Design of Small Molecules
businesswire.com
TAK
ICMB
Alira Health Opens the Registration for the Third Edition of the Global Payer Forum
globenewswire.com
TAK
Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE ® Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead
businesswire.com
TAK
Exosome Therapy Market Projected to Reach US$ 309.60 Billion by 2035, Supported by Clinical Translation and Manufacturing Scale-Up Says Astute Analytica
globenewswire.com
TAK
JAZZ
Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content 1
businesswire.com
TAK
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight
globenewswire.com
LULU
LIVN
AXSM
TAK
JAZZ
VNDA
LLY
AVDL
Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics
globenewswire.com
ONCY
CGON
TAK